ACM
RMD icon

Andina Capital Management’s ResMed RMD Stock Holding History

Andina Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,988
Closed -$479K – 166
2025
Q4 		$479K Buy
1,988
+56
+3% +$14.3K 0.29% 83
2025
Q3 		$529K Buy
1,932
+77
+4% +$21K 0.3% 77
2025
Q2 		$479K Buy
1,855
+81
+5% +$19.3K 0.34% 75
2025
Q1 		$397K Buy
+1,774
New +$414K 0.28% 86

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Andina Capital Management's RMD Position: Q1 2026 in Review

Andina Capital Management sold out of ResMed (RMD) in Q1 2026, closing a stake of 1,988 shares — an estimated $479K sold.

Andina Capital Management first reported a position in RMD in Q1 2025 and held it in 4 quarters. The position peaked at $529K in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Andina Capital Management reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
  • Andina Capital Management sold 1,988 ResMed shares in Q1 2026, an estimated $479K.
  • Andina Capital Management first reported a position in ResMed in Q1 2025 and held it in 4 quarters.
  • Andina Capital Management's ResMed position peaked at $529K in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Andina Capital Management's 13F filing for Q1 2026, filed 17 Apr 2026.